Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company LifeSplice Pharma LLC
DescriptionSplice modulating oligomer (SMO) that reduces the expression of the GluA1-flip isoform
Molecular Target AMPA 1 glutamate receptor (GRIA1) (GLUR1)
Mechanism of Action 
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today